Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
2 hedge funds and large institutions have $28K invested in Kitov Pharma Ltd. Warrants in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
33% less funds holding
Funds holding: 3 → 2 (-1)
87% less capital invested
Capital invested by funds: $212K → $28K (-$184K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$30.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$130K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$28.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $21K | +$30.5K | +40,573 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $7K | -$28.1K | -37,270 | -73% |
|
|
ICM
3
Ionic Capital Management
New York
| – | -$130K | -97,221 | Closed |
|
KTOVW Hedge Fund Activity: Q1 2017 in Review
2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q1 2017, worth a combined $28K — down 87% from $212K a quarter earlier.
Fund positioning in KTOVW was balanced in Q1 2017: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $30.5K. The largest seller was Ionic Capital Management, exiting entirely with an estimated $130K sold.
- 2 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q1 2017, down from 3 in Q4 2016.
- Funds reported $28K of Kitov Pharma Ltd. Warrants stock for Q1 2017, down 87% quarter-over-quarter.
- 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q1 2017 and 1 closed out, a net change of 0 holders.
- The largest Kitov Pharma Ltd. Warrants buyer in Q1 2017 was Virtu KCG Holdings, an estimated $30.5K added.
- The largest Kitov Pharma Ltd. Warrants seller in Q1 2017 was Ionic Capital Management, an estimated $130K sold.
Based on aggregated 13F filings for Q1 2017.